ABT - ABBOTT LABORATORIES


113.1
-0.510   -0.451%

Share volume: 4,603,868
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$113.61
-0.51
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-02-2024 07-31-2024 10-31-2024 02-21-2025 04-30-2025 07-30-2025 10-29-2025 02-20-2026
Cash flow financing -1.176 B -791.000 M -1.576 B -1.861 B -2.055 B -1.097 B -1.760 B -1.397 B
Other financing cash flows 134.000 M 13.000 M 92.000 M 25.000 M 287.000 M 35.000 M 69.000 M 5.000 M
Cash flow -576.000 M 716.000 M 535.000 M 141.000 M -1.108 B 368.000 M 570.000 M 1.005 B
Net income 1.225 B 1.302 B 1.646 B 9.229 B 1.325 B 1.779 B 1.644 B 1.776 B
Depreciation 333.000 M 334.000 M 331.000 M 342.000 M 336.000 M 357.000 M 371.000 M 370.000 M
Changes in inventories 410.000 M 0.000 0.000 0.000 255.000 M 0.000 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -425.000 M -453.000 M -594.000 M -866.000 M -470.000 M -582.000 M -457.000 M -913.000 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 1.000 M 2.000 M 2.000 M 4.000 M 6.000 M 2.000 M 4.000 M 6.000 M
Dividends Paid -957.000 M -961.000 M -960.000 M -958.000 M -1.026 B -1.029 B -1.031 B -1.030 B
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 398.000 M 533.000 M 556.000 M 720.000 M 484.000 M 502.000 M 496.000 M 689.000 M
Cash Change -612.000 M 703.000 M 571.000 M 58.000 M -1.084 B 419.000 M 560.000 M 1.011 B